Comments

Artelo Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Artelo Biosciences (ARTL) operate in?

Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ARTLNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$7.20

0.111.56%

At close: -

$6.80

-0.40-5.49%

After Hours: Jun 13, 6:37 PM EDT

Artelo Biosciences Inc is expected to split Friday, June 13, 2025 with a ratio of 1:6

Artelo Biosciences (ARTL) Forecast

News Earnings Artelo Biosciences (ARTL) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Artelo Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ARTL | Benzinga

Explore Artelo Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ARTL.

Open	$6.38
Close	$7.20
Volume / Avg.	39.67K / 67.13K
Day Range	$6.20 - $7.35
52 Wk Range	4.92 - 9.30
Market Cap	$22.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	35.53%
Days to Cover	2.66

Recent News

This UnitedHealth Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Avi Kapoor

EXCLUSIVE: Artelo Biosciences' New Peer-Reviewed Research Shows Effectiveness Of Psoriasis Candidate In Animal Models

Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia studies.

Vandana Singh

EXCLUSIVE: Artelo Biosciences Concludes First Cohort Of Healthy Volunteers Of FABP Inhibitor Program

Artelo Biosciences advances its pipeline with ART26.12 for neuropathic pain and ART27.13 for cancer-related anorexia, targeting 2025 milestones.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.38
Close	$7.20
Volume / Avg.	39.67K / 67.13K
Day Range	$6.20 - $7.35
52 Wk Range	4.92 - 9.30
Market Cap	$22.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	35.53%
Days to Cover	2.66

About Artelo Biosciences Inc

Sector

Health Care

Industry

Pharmaceuticals

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is e...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Artelo Biosciences (ARTL) stock?

You can purchase shares of Artelo Biosciences (NASDAQ:ARTL) through any online brokerage.

View our list of the best stock brokerages

Who are Artelo Biosciences (ARTL) competitors?

Other companies in Artelo Biosciences’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and SCYNEXIS (NASDAQ:SCYX).

What is the forecast, or price target, for Artelo Biosciences (ARTL) stock?

Artelo Biosciences has a consensus price target of $23.67.

What is the current price for Artelo Biosciences (ARTL)?

The stock price for Artelo Biosciences (NASDAQ: ARTL) is $6.8 last updated June 13, 2025 at 6:37 PM EDT.

Does Artelo Biosciences (ARTL) pay a dividend?

There are no upcoming dividends for Artelo Biosciences.

When is Artelo Biosciences (NASDAQ:ARTL) reporting earnings?

Artelo Biosciences’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Artelo Biosciences (ARTL) going to split?

There is no upcoming split for Artelo Biosciences.

What sector and industry does Artelo Biosciences (ARTL) operate in?

Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.